Details

OPPORTUNITY

Offering a game changing, non-invasive diagnostic platform technology which saves lives through higher accuracy, faster results, and improved patient experience.

  • KEY HIGHLIGHTS

    • Established 2004
    • Current patient trials underway at major NHS Hospitals throughout the UK
    • Large patent portfolio across the world, with further pending
    • Clinical Trial Partners in the US engaged and supportive
    • Includes the IPR for a specialised cell concentration & preservation collection device, a clinically validated Biomarker and utilises AI for automated analysis of results
    • 2MIllion Euro + £4.4M Investment to 2020
    • Initial core technology as a result of a £12million pound research project funded by Cancer Research UK and Cambridge University.
  • Historic Valuation of business at circa £8 Million

Please download Notice For Sale for further information

Viewing Details

EXPRESSIONS OF INTEREST

  • Interested parties will be required to sign a nondisclosure agreement (NDA) before further information is
  • Expressions of interest are required by 12noon on Friday 12th August 2022 together with proof of funding with completion as soon possible
REQUESTS FOR AN NDA SHOULD BE SENT TO :-
RICHARD TEMPLE ([email protected])

0113 209 1052

or
ABBIE HICKMAN ([email protected])

0114 551 2527

Location

Aberdeen, Scotland 

Status

For Sale

Method

Business for Sale

Bidding ends

Ref

Project Cell

Category

Business & Trading Assets